- Home
- ROMA vs INO Comparison
ROMA vs INO Comparison
Compare ROMA & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ROMA | INO |
|---|---|---|
| Founded | 2018 | 1979 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.6M | 114.0M |
| IPO Year | 2022 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ROMA | INO |
|---|---|---|
| Price | $4.66 | $1.63 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 536.1K | ★ 720.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 54.18 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $42,220,086.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23,060.18 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 19.37 |
| 52 Week Low | $0.72 | $1.30 |
| 52 Week High | $8.88 | $2.86 |
Technical Indicators
Market Signals| Indicator | ROMA | INO |
|---|---|---|
| Relative Strength Index (RSI) | 66.24 | 42.91 |
| Support Level | $2.05 | $1.48 |
| Resistance Level | $8.88 | $1.78 |
| Average True Range (ATR) | 0.91 | 0.08 |
| MACD | 0.31 | -0.01 |
| Stochastic Oscillator | 41.59 | 11.59 |
Price Performance
Historical ComparisonAbout ROMA Roma Green Finance Limited
Roma Green Finance Ltd is principally engaged in the provision of ESG, corporate governance and risk management as well as sustainability and climate change-related advisory services. The company works closely with its clients to help them understand, identify, manage, and overcome various business matters arising from such factors related to ESG, sustainability and climate change. Geographically, the company generates its revenue from Hong Kong and Singapore.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.